Merck

MRK · NYSE · USD

$144.30+0.34%+$0.49

Close · October 2, 2026

At a glance

Revenue growth: +1.31%; 2025 vs 2024
Net income growth: +6.64%; 2025 vs 2024
Net margin: 28.1%; 2024: 26.7%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total assets	136,866	117,106	106,675	109,160	105,694	91,588	84,397	82,637	87,872	95,377
Current assets	43,516	38,782	32,168	35,722	30,266	27,764	27,483	25,875	24,766	30,614
Cash and equivalents	14,565	13,242	6,841	12,694	8,096	8,050	9,676	7,965	6,092	6,515
Short-term investments	0.0	447	252	498	—	—	774	899	2,406	7,826
Receivables	12,706	11,127	11,072	10,621	10,779	7,240	7,105	7,226	6,918	7,018
Inventory	6,658	6,109	6,358	5,911	5,953	5,554	5,978	5,440	5,096	4,866
Net property, plant and equipment	26,823	25,149	24,488	22,768	20,865	18,688	16,126	13,291	12,439	12,026
Goodwill	21,579	21,668	21,197	21,204	21,264	18,882	19,425	18,253	18,284	18,162
Other intangible assets	26,681	16,370	18,011	20,269	22,933	14,101	14,196	13,104	14,183	17,305
Long-term investments	2,082	1,610	1,558	2,445	966	1,425	1,904	6,801	12,125	11,436
Current liabilities	28,327	28,420	25,694	24,239	23,872	27,327	22,220	22,206	18,614	17,204
Accounts payable	4,515	4,999	4,434	5,160	6,389	4,665	4,315	4,098	3,102	2,807
Long-term debt	46,750	34,462	33,683	28,745	30,690	25,360	22,736	19,887	21,405	24,303
Total debt	50,245	38,121	36,196	31,739	34,519	29,286	25,641	19,887	24,408	24,603
Total liabilities	84,204	70,734	69,040	63,102	67,437	66,184	58,396	55,755	53,303	55,069
Total equity (incl. minority)	52,662	46,372	37,635	46,058	38,257	25,404	26,001	26,882	34,569	40,308
Retained earnings	73,075	63,069	53,895	61,081	53,696	47,362	46,602	42,579	41,350	44,133
Minority interest	56.0	59.0	54.0	67.0	73.0	87.0	94.0	181	233	220